Risk of SARS-CoV-2 reinfection after natural infection

Lancet. 2021 Mar 27;397(10280):1161-1163. doi: 10.1016/S0140-6736(21)00662-0. Epub 2021 Mar 17.

Authors

Rosemary J Boyton¹, Daniel M Altmann²

Affiliations

¹ Department of Infectious Disease, Imperial College London, London W12 0NN, UK; Lung Division, Royal Brompton Hospital, London, UK. Electronic address: [email protected].
² Department of Immunology and Inflammation, Imperial College London, London, UK.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Denmark
Humans
Polymerase Chain Reaction
Reinfection
SARS-CoV-2*

Grants and funding